TransCode Therapeutics receives Nasdaq deficiency notice for low stockholders' equity of $1.25M vs $2.5M minimum

Transcode Therapeutics, Inc.

Stockholders' equity as of March 31, 2026 was $1,251,427, below Nasdaq's $2,500,000 minimum requirement.
Company has 45 days (until July 3, 2026) to submit a compliance plan to Nasdaq.
If plan accepted, Nasdaq may grant up to 180-day extension to regain compliance.
Failure to regain compliance could lead to delisting of common stock (RNAZ) from Nasdaq Capital Market.

item 3.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-26-065728
form_type: 8-K
ticker: RNAZ
cik: 0001829635
company_name: Transcode Therapeutics, Inc.
filed_at: 2026-05-22T20:15:37+00:00
discovered_at: 2026-05-22T20:17:00.302363+00:00
generated_at: 2026-05-22T20:18:14.789344+00:00
sec_items: ["3.01"]
event_type: regulatory
sentiment: negative
materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-26-065728
json_url: https://secwatch.observer/filing/0001104659-26-065728.json
markdown_url: https://secwatch.observer/filing/0001104659-26-065728.md
text_url: https://secwatch.observer/filing/0001104659-26-065728.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1829635/000110465926065728/0001104659-26-065728-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1829635/000110465926065728/tm2615385d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

9687284dc7e3a19aeab306227984f7b56ae2488a

Transcode Therapeutics, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

On May 19, 2026, TransCode Therapeutics, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market.

SEC 8-K Item 3.01 confidence 0.95 SEC evidence

Source: SEC EDGAR

accession 0001104659-26-065728

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.